Soy allergy following early soy feeding in neonates

Nimrod Nachmias1, Yaakov Landman, Yehuda L Danon

  • 1Kipper Institute of Immunology, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.

Insights

Early soy-based formula supplementation in newborns does not appear to increase the risk of soy allergy. This study followed 982 infants for six months, finding no significant allergic reactions to soy formula.

Area of Science:

  • Pediatrics
  • Allergology
  • Neonatology

Background:

  • Concerns exist regarding potential milk allergy increase from humanized milk formula in neonates.
  • Limited prospective studies evaluate the allergenic effects of early soy-based formula (SBF) feeding.

Purpose of the Study:

  • To determine the prevalence of soy allergy in infants introduced to SBF within the first three days of life.

Main Methods:

  • A cohort of 982 healthy, full-term infants receiving routine SBF supplementation was monitored.
  • In-hospital feeding data was collected, and parents were interviewed monthly for six months about feeding and allergy symptoms.

Main Results:

  • 99% of infants received SBF in the hospital, with 33%-42% continuing at home.
  • No immediate allergic reactions to soy or soy-induced enterocolitis were reported during the follow-up period.

Conclusions:

  • Introducing soy-based formula during the early neonatal period does not seem to elevate the incidence of soy allergy.
  • Infants followed for six months showed no increased prevalence of soy allergy when supplemented with SBF early on.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Allergic Reactions02:06

Allergic Reactions

Overview
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...